Delivery Order SPE2DB22D2206-SPE2DB24FFW05
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Jardiance 10 mg tablets for the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order valued at $3,458.02 with a completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for...
- This federal contract award is a Delivery Order valued at $11,739.07 that was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Jardiance 25 mg tablets. The Firm Fixed Price delivery order, valued at $17,732.76, has a completion date of November 8, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the delivery of pharmaceutical products, primarily focused on the drug Jardiance 25 mg tablet, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,646.91 and an ultimate completion date of November 15, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of the drug Jardiance 10 mg tablets. The $6,271.56 firm-fixed-price delivery order has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of Jardiance 25mg tablets. The $2,445.07 firm fixed-price delivery order has a completion date of November 19, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $19,608.77 firm-fixed-price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, with a completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,861.37 Firm Fixed Price Delivery Order is for the supply of 90 tablets of the prescription drug Jardiance 10 mg. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,337.23, is a delivery order for the supply of Jardiance 25 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order with a firm fixed price of $6,441.30 for the supply of the pharmaceutical product Jardiance 10 mg tablet. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for a period ending on April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFW05Delivery Order
This federal contract award is for the delivery of pharmaceutical products, primarily focused on the drug Jardiance 25 mg tablet, to the Defense Logistics Agency (DLA). The $6,162.17 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of March 1, 2024 and was not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 2/29/24 |